0.00Open0.00Pre Close0 Volume0 Open Interest69.00Strike Price0.00Turnover244.93%IV-13.77%PremiumDec 13, 2024Expiry Date11.02Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8668Delta0.0187Gamma7.18Leverage Ratio-0.8146Theta0.0020Rho6.22Eff Leverage0.0101Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet